Harvard-Partners Transfers Cardio Tests to Affy Platform to Cut Cost, Turnaround Time

Last month, HPCGG’s Laboratory of Molecular Medicine began offering a test for hypertrophic cardiomyopathy based on an Affy-manufactured resequencing array. The test, called the HCM CardioChip, can detect mutations in 11 genes associated with the disease.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.